Wuxi Pharmatech (PRIVATE.WX)

Wuxi PharmaTech (Cayman) Inc. operates as a pharmaceutical, biotechnology, and medical device research and development services company in China and the United States. It operates through two segments, Laboratory Services and Manufacturing Services. The Laboratory Services segment offers services for small molecules, such as synthetic chemistry, biology, medicinal chemistry, DMPK/ADME, formulation, analytical chemistry, toxicology, clinical development, bioanalytical, genomics, bioinformatics, research reagent production, and clinical services. It also provides services for the discovery and development of biologics, as well as laboratory services that include testing services for biologics, medical devices, and combination products, in addition to the production of cell therapies. The Manufacturing Services segment provides manufacturing services, including the development of manufacturing processes. It also produces advanced intermediates and active pharmaceutical ingredients for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products. The company sells its products to pharmaceutical, biotechnology, and medical device companies, as well as academic institutions and non-profit organizations. Wuxi PharmaTech (Cayman) Inc. was founded in 2000 and is headquartered in Shanghai, China.